Biosecurity, biodefense and outbreak response organisations.
Loading organisations…
Clear filters
15 organisations in Biological
Sort Best match · Name
BioFactura develops antibody therapies for smallpox and viral hemorrhagic fevers. CBRNE-relevant work is a primary business line according to its website. It is headquartered in Frederick, MD, United States.
Elusys Therapeutics makes an anthrax antitoxin therapy. CBRNE-relevant work is a primary business line according to its website.
Mapp Biopharmaceutical develops antibody therapeutics against Ebola and other biothreat viruses. CBRNE-relevant work is a primary business line according to its website.
Bavarian Nordic is a Danish vaccine company that supplies JYNNEOS, a non-replicating smallpox and mpox vaccine, to governments for preparedness. Its US government work includes a long-running BARDA contract for freeze-dried JYNNEOS, and it also has European Commission and other national supply agreements.
Cellphire develops freeze-dried platelet products funded for radiation-related injury. CBRNE-relevant work is a notable product line according to its website. It is headquartered in Rockville, MD, United States.
Emergent BioSolutions develops and supplies medical countermeasures for anthrax, smallpox, chemical and radiological threats. CBRNE-relevant work is a notable product line according to its website.
GeoVax is a US clinical-stage vaccine company developing GEO-MVA, an investigational smallpox and mpox vaccine. Its BARDA Project NextGen award was terminated in April 2025, and the company said clinical trials of the vaccine were planned for 2025.
SIGA Technologies develops and supplies a smallpox antiviral treatment for government stockpiles. CBRNE-relevant work is a notable product line according to its website. It is headquartered in New York, NY, United States.
Soligenix develops biodefense vaccines and therapeutics including for radiation injury. CBRNE-relevant work is a notable product line according to its website.
Appili Therapeutics develops anti-infectives for biodefence threats. CBRNE-relevant work is a minor part of its offering according to its website. It is headquartered in Halifax, Canada.
Dynavax makes the CpG 1018 vaccine adjuvant and has a plague vaccine candidate (rF1V-1018) that completed a Phase 2 trial under a US Department of Defense programme.
Paratek Pharmaceuticals develops antibiotics including for biothreat pathogens. CBRNE-relevant work is a minor part of its offering according to its website. It is headquartered in Boston, MA, United States.
Regeneron makes Inmazeb (REGN-EB3), an FDA-approved Ebola antibody treatment that BARDA has supported through development and procurement for national preparedness stockpiles.
Tonix Pharmaceuticals was awarded up to $34 million by the US Department of Defense for a broad-spectrum antiviral programme, TNX-4200.
Xcmr Inc offers products or services in these areas, according to its website: biodefense contractors, medical countermeasure developers, threat detection & diagnostics. CBRNE-relevant work is a minor part of its offering according to its website. It is headquartered in PA, United States.